Search results for: Indication-Based Pricing
Filter search results
What is the impact of Uniform Pricing, Indication-Based Pricing (IBP) and alternative commercial arrangements for new pharmaceuticals in the UK NHS?
19 November 2024
…about the availability of commercial flexibilities, including for indication-specific pricing (referred to here as indication-based pricing [IBP]). During the consultation process for phase 1 Woods and colleagues published a paper funded by the NIHR Policy…
Indication-Based Pricing: Are We All Onboard?
12 May 2020
…Zamora, B., 2019. Indication-Based Pricing (IBP) Discussion Paper. OHE Briefing, London: Office of Health Economics. Available at: https://www.ohe.org/publications/indication-based-pricing-ibp-discussion-paper-should-drug-pricesdiffer-indication Cole, A., Towse, A., Lorgelly, P. and Sullivan, R. (2018). Economics of…
Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
1 May 2019
Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a way to better…
OHE Launches Discussion Paper and Consultation Exercise on Indication-based Pricing
10 May 2019
…system to support different indications for a different indication of a medicine: indication-based pricing (IBP). OHE previously launched a Discussion Paper (now also available in Spanish), which outlines the key potential…
Indication-Based Pricing (IBP) Consultation Report
1 April 2020
…(or even more importantly the unrealised potentialto treat multiple indications), the way we pay for those medicines becomes critical in making sure we can benefit from them. “Indication-based pricing” (IBP)…
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
…be achieved, when increasingly medicines are being developed that derive patient benefit across many different indications? Indication-based pricing (IBP) has been proposed as a way to tackle this issue, permitting…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…indications? Indication-based pricing (IBP) has been proposed as a way to tackle this issue, permitting price to vary according to indication and – critically – according to value. The notion…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
Multi-Indication Pricing: Practical Solutions and Steps to Move Forward. A summary of an HTAi panel session. We have just published a new OHE Briefing entitled ‘Multi-Indication Pricing: Practical Solutions and…
Payment Models for Multi-Indication Therapies
1 November 2021
…A., Zamora, B. (2020) Indication-Based Pricing (IBP) Consultation Report. OHE Consulting Report. Available from https://www.ohe.org/publications/indication-based-pricing-ibp-consultation-report. Neri, M., Towse, A. and Garau, M., 2018. Multi-Indication Pricing (MIP): Practical Solutions and Steps…